Skip to content

Mandibular Muscle Energy Technique in Patients With Mandibular Joint Pathology and Bruxism

Immediate Effects of the Mandibular Muscle Energy Technique in Patients With Mandibular Joint Pathology and Bruxism. Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05594511
Enrollment
60
Registered
2022-10-26
Start date
2022-04-25
Completion date
2023-06-23
Last updated
2023-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Disorders, Bruxism, Pain Threshold, Kinesiophobia

Brief summary

This is a randomized, controlled, double-blind clinical trial. The main objective is to evaluate the immediate effect of the mandibular muscle-energy technique on pain, functionality and kinesiophobia in subjects suffering from temporomandibular dysfunction and bruxism. In the experimental group the jaw muscle-energy technique will be applied and in the control group a placebo technique will be applied. The intention is to see the immediate effects of the intervention and two evaluations of the pre- and post-intervention outcome variables and a follow-up of kinesiophobia one week later will be performed.

Interventions

PROCEDUREMuscle-energy mandibular technique

A single session will be used with the mandibular musculoenergy technique. It will last approximately 2-3 minutes and will be performed by a physiotherapist.

A single session with a sham technique simulating the suboccipital muscle inhibition technique will be used. It will last approximately 2-3 minutes and will be performed by a physiotherapist.

Sponsors

Instituto de Investigación Biomédica de Salamanca
CollaboratorOTHER
University of Salamanca
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The participants will be blinded because in both groups they were following the treatment and medical recommendations and they will also be attended by a physiotherapist, in one case the mandibular muscular energy technique will be performed and in the other the placebo technique. The evaluators did not know to which group the participants belonged.

Intervention model description

randomized, controlled, prospective, double-blind, clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients who agree to participate in the study by signing the informed consent form. * Patients attending maxillofacial consultation with pain, temporomandibular dysfunction and bruxism. * Pain of at least 3 months of evolution.

Exclusion criteria

* Patients with congenital malformations or cervical spine pathology. * Infectious or inflammatory disease in its acute phase. * Patients with vertigo or vestibular alterations. * If there is a contraindication to the technique or phobia on the part of the patient. * Physiotherapy treatment (manual therapy or electrotherapy) in the last month before their incorporation in the study. * Pharmacological treatment (analgesics, relaxants and anti-inflammatory drugs) in the last 24 hours before the initial evaluation.

Design outcomes

Primary

MeasureTime frameDescription
Changes in craniofacial pain intensity2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.For the subjective evaluation of craniofacial pain, the visual analog scale (VAS) will be applied. Scale from 0 (no pain at all) to 10 (maximum possible pain).

Secondary

MeasureTime frameDescription
Changes in rightward mandibular translation2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.The active rightward mandibular translation will be measured using a digital caliper
Changes in leftward mandibular translation2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.The active leftward mandibular translation will be measured using a digital caliper
Changes in Pressure pain threshold at myofascial trigger point (PT1) of the both upper trapezius muscles2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.The pressure threshold will be recorded using a digital algometer
Changes in mouth opening mobility2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.The active opening of the mouth will be measured using a digital caliper
Changes in pressure pain threshold at myofascial trigger point of the both digastric muscles2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.The pressure threshold will be recorded using a digital algometer
Changes in kinesiophobia2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group. And a follow-up after one weekThe Kinesiophobia will be recorded using the spanish version of the Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD-S). It is a valid and reliable instrument for measuring kinesiophobia in patients with TMD, and it uses a Likert scale (1-4) containing 11 items in 2 domains, with higher scores indicating higher levels of kinesiophobia (0-44).
Changes in pressure pain threshold at myofascial trigger point of the both external pterygoid muscles2 evaluations, one pre-intervention and one post-intervention, 5 minutes after the end of the intervention according to the assigned group.The pressure threshold will be recorded using a digital algometer

Countries

Spain

Contacts

Primary ContactRoberto Méndez-Sánchez, PhD
ro_mendez@usal.es+34 923294500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026